PMID- 16375693 OWN - NLM STAT- MEDLINE DCOM- 20060120 LR - 20211203 IS - 1568-0088 (Print) IS - 1568-0088 (Linking) VI - 5 IP - 4 DP - 2005 Dec TI - The new immunosuppression: intervention at the dendritic cell-T-cell interface. PG - 397-411 AB - Dendritic cells (DCs) play an important role in initiating and directing T-cells towards immunity or tolerance. An important aim of emerging immunosuppressive strategies is to ensure that antigen is perceived in a 'tolerogenic context'. This would have obvious benefit in minimising the need for long-term drug maintenance in organ transplantation, hypersensitivity and autoimmune diseases. Here we review the biology of the interplay between the DC and T-cell, with a specific focus on therapeutic drugs targeting molecules that effect their interaction and function. FAU - Paterson, A M AU - Paterson AM AD - Sir William Dunn School of Pathology, University of Oxford, South Parks Road, UK. alison.paterson@path.ox.ac.uk FAU - Yates, S F AU - Yates SF FAU - Nolan, K F AU - Nolan KF FAU - Waldmann, H AU - Waldmann H LA - eng PT - Journal Article PT - Review PL - United Arab Emirates TA - Curr Drug Targets Immune Endocr Metabol Disord JT - Current drug targets. Immune, endocrine and metabolic disorders JID - 101121150 RN - 0 (Antibodies, Monoclonal) RN - 0 (Immunosuppressive Agents) SB - IM MH - Animals MH - Antibodies, Monoclonal/*pharmacology MH - Dendritic Cells/drug effects/*immunology MH - Graft Rejection/immunology/prevention & control MH - Humans MH - Immune Tolerance MH - *Immunosuppression Therapy MH - Immunosuppressive Agents/*pharmacology MH - T-Lymphocytes/drug effects/*immunology RF - 222 EDAT- 2005/12/27 09:00 MHDA- 2006/01/21 09:00 CRDT- 2005/12/27 09:00 PHST- 2005/12/27 09:00 [pubmed] PHST- 2006/01/21 09:00 [medline] PHST- 2005/12/27 09:00 [entrez] AID - 10.2174/156800805774912935 [doi] PST - ppublish SO - Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):397-411. doi: 10.2174/156800805774912935.